Biohaven Pharmaceutical Holding Company Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 114.26 | -100% | -6.08 | -100% |
| P/S |
|
13.12 | 4.1 | 219.74% |
|
|
| P/BV |
|
7.2 | 9.02 | -20.21% |
|
|
| P/FCF |
|
-3.94 | 44.54 | -108.85% |
|
|
| Ev/Ebitda |
|
-6.62 | 17.72 | -137.33% |
|
|
| Ev/S |
|
3.88 | 4.4 | -11.87% |
|
|
| Ev/FCF |
|
-8.55 | 54.7 | -115.63% |
|
|
| E/P |
|
-0.3092 | 0.2136 | -244.73% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-58.67 | 21.49 | -373.04% | -260.8 | -77.5% |
| ROE |
|
-95.37 | -82.41 | 15.73% |
|
|
| ROA |
|
-79.53 | 6.75 | -1278.1% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-55.34 | 10.29 | -637.89% |
|
|
| ROCE |
|
-101.89 | 55.43 | -283.83% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0714 | 0.9571 | -107.46% | -0.6328 | -88.72% |
| Nеt Debt/Ebitda |
|
0.5058 | 2.1 | -75.86% |
|
|
| Debt/Ratio |
|
0.0602 | 0.2655 | -77.34% |
|
|
| Debt/Equity |
|
0.0526 | 4.83 | -98.91% |
|
|
| Debt/Net Income |
|
-0.0756 | 35.64 | -100.21% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.3 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.35 | -100% | ||
| DSI |
|
0 | 0.7478 | -100% |
|
|
| Average dividend growth |
|
0 | -1.49 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.29 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.77 | -100% |
|
|
| Difference from average difference in sector |
|
-1.3 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
622.66 | 214.83 | 189.84% | ||
| Growth impulse Ebitda in 5 years |
|
-18.69 | 253.48 | -107.37% | ||
| Growth impulse Net Income in 5 years |
|
-22.84 | 270.34 | -108.45% | ||
| Growth impulse FCF in 5 years |
|
-12.13 | 183.09 | -106.63% | ||
| Growth impulse EPS in 5 years |
|
-47.46 | 149.95 | -131.65% |
IP Score
3.14/10
